Cleared Traditional

K852589 - TDX IMMUNOGLOBULIN G DIAGNOSTIC KIT

K852589 is an FDA 510(k) clearance for TDX IMMUNOGLOBULIN G DIAGNOSTIC KIT, manufactured by Abbott Laboratories. The device is a Class 2 Immunology device with product code DEW cleared through the Traditional 510(k) pathway after a 27-day FDA review.

K852589 · Abbott Laboratories · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1985
Decision
27d
Days
Class 2
Risk

K852589 is an FDA 510(k) clearance for the TDX IMMUNOGLOBULIN G DIAGNOSTIC KIT. Classified as Igg, Antigen, Antiserum, Control (product code DEW), Class II - Special Controls.

Submitted by Abbott Laboratories (Irving, US). The FDA issued a Cleared decision on July 15, 1985 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K852589

510(k) Number K852589 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 1985
Decision Date July 15, 1985
Days to Decision 27 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 104d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DEW Device Classification - Class 2, Special Controls

Product Code DEW Igg, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DEW Igg, Antigen, Antiserum, Control

All 55
Devices cleared under the same product code (DEW) and FDA review panel - the closest regulatory comparables to K852589.
TINA-QUANT(R) IGG
K862764 · Boehringer Mannheim Corp. · Sep 1986
DAKO ITA SYSTEM
K861059 · Dako Corp. · Aug 1986
DART IMMUNOGLOBULINS REAGENT SYSTEM
K851541 · Coulter Electronics, Inc. · Jul 1985
AMER. HISTO-ID SYS PRIMARY IGG S7920-11
K842329 · Bartels Immunodiagnostic Supplies, Inc. · Aug 1984
OPTIMATE IGG TEST
K841816 · Miles Laboratories, Inc. · Jun 1984
TECH. RA-1000SYS-ANALYTES IMMUNOGLOBULIN
K833402 · Technicon Instruments Corp. · Jan 1984